Orthofix Medical (Orthofix Medical) Interest Expense : $-11.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Orthofix Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Orthofix Medical's interest expense for the three months ended in Mar. 2024 was $ -4.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Orthofix Medical's Operating Income for the three months ended in Mar. 2024 was $ -23.9 Mil. Orthofix Medical's Interest Expense for the three months ended in Mar. 2024 was $ -4.6 Mil. Orthofix Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orthofix Medical Interest Expense Historical Data

The historical data trend for Orthofix Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Interest Expense Chart

Orthofix Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.12

-2.48

-1.84

-1.29

-8.63

Orthofix Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.29	-1.27	-1.58	-4.50	-4.56

Orthofix Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.9 Mil.

Orthofix Medical (NAS:OFIX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orthofix Medical's Interest Expense for the three months ended in Mar. 2024 was $-4.6 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-23.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $133.4 Mil.

Orthofix Medical's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Orthofix Medical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Orthofix Medical (Orthofix Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

OM2:Germany

Address

3451 Plano Parkway, Lewisville, TX, USA, 75056

Website

https://www.orthofix.com

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Executives

James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha	officer: CECO & Interim CLO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie	officer: VP, Controller, Interim CFO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny	officer: President of Global Spine	C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic	officer: CFO	C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine	director, officer: President & CEO	7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran	officer: Chief Legal Officer	6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West	director	C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci	director	7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik	director
Rice Doug	officer: CFO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting	officer: Chief Legal Officer	3451 PLANO PARKWAY, LEWISVILLE TX 75056